Placebo-controlled Study in Patients With Parkinson's Disease to Evaluate the Effect of Rotigotine on Non-motor Symptoms

NCT01300819 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

349

Enrollment

INDUSTRY

Sponsor class

Conditions

Idiopathic Parkinson's Disease

Interventions

OTHER: Placebo
DRUG: Rotigotine

Sponsor

UCB Pharma